Stock listing

Cardiol Therapeutics Inc. Class A (CT9) Stock Price, News, Filings & Events

Selected listing: CT9 · TRADEGATE · EUR · DE

CT9:TRADEGATE is the listing for Cardiol Therapeutics Inc. Class A, a Canadian public company dedicated to developing innovative therapies for cardiovascular diseases. With a market capitalization of approximately €122.3 million, Cardiol is actively engaged in research and development to tackle significant unmet medical needs in this area. Recent news and filings highlight the company's ongoing commitment to advancing its therapeutic solutions and its position within the healthcare market.

websiteCT9:TRADEGATEEURDESEO content: aiUpdated June 24, 2026/stock/tradegate-ct9/cardiol-therapeutics-inc-class-a/l-9gvs88us9i
Cardiol Therapeutics Inc. Class A logo
Ticker
CT9:TRADEGATE
Asset type
Stock
Market cap
$122.3M
Sector
Health Technology
Industry
Biotechnology
Exchange
TRADEGATE
Currency
EUR

Cardiol Therapeutics Inc. Class A CT9:TRADEGATE stock context

CT9:TRADEGATE is the listing for Cardiol Therapeutics Inc. Class A, a Canadian public company dedicated to developing innovative therapies for cardiovascular diseases. With a market capitalization of approximately €122.3 million, Cardiol is actively engaged in research and development to tackle significant unmet medical needs in this area. Recent news and filings highlight the company's ongoing commitment to advancing its therapeutic solutions and its position within the healthcare market.

Research Cardiol Therapeutics Inc. Class A

Alternate listings